Search Within

Michael Andrew Postow

Formats
  1. Journal Article (196)
  2. Meeting Abstract (138)
  3. Review (10)
  4. Editorial (9)
  5. Book Section (4)
  6. Guidelines (4)
  7. Research Letter (4)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Department of Medicine (369)
  2. Melanoma Disease Management Team (369)
  3. Melanoma and Immunotherapeutics Service (369)
  4. Solid Tumor Oncology Division (369)
  5. GSK Faculty (178)
  6. Hematologic Malignancies, Division of (105)

More Groups

People
  1. Jedd Wolchok (158)
  2. Margaret Callahan (96)
  3. Katherine Panageas (66)
  4. Alexander Shoushtari (64)
  5. Paul Chapman (55)
  6. Parisa Momtaz (37)

More People

Years
  1. 2025 (23)
  2. 2024 (19)
  3. 2023 (23)
  4. 2022 (23)
  5. 2021 (27)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (92)
  2. Journal for ImmunoTherapy of Cancer (34)
  3. Clinical Cancer Research (16)
  4. Annals of Oncology (13)
  5. International Journal of Radiation Oncology, Biology, Physics (12)
  6. The Oncologist (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. Biomed Central Ltd (43)
  3. Elsevier Inc. (32)
  4. Oxford University Press (32)
  5. American Association for Cancer Research (24)
  6. Wiley Blackwell (21)

More Publishers

Results (369)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of absolute and relative eosinophil counts with immune-related adverse events in melanoma patients treated with ipilimumab
    Meeting Abstract

    Schindler, K.; Harmankaya, K.; Kuk, D.; Mangana, J.; Michielin, O.; Hoeller, C.; Dummer, R.; Pehamberger, H.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Assessment of overall survival from time of metastastasis in mucosal, uveal, and cutaneous melanoma
    Meeting Abstract

    Postow, M. A.; Kuk, D.; Bogatch, K.; Carvajal, R. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The neoantigen landscape underlying clinical response to ipilimumab
    Meeting Abstract

    Snyder Charen, A.; Makarov, V.; Merghoub, T.; Walsh, L.; Yuan, J.; Miller, M.; Kannan, K.; Postow, M. A.; Elipenahli, C.; Liu, C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The Memorial Sloan Kettering Cancer Center (MSKCC) experience of systemic therapy in mucosal melanoma
    Meeting Abstract

    Bitas, C.; Shoushtari, A. N.; Bluth, M. J.; Bhuchar, G.; Hester, R. H.; Romero, J.; Fitzpatrick, L.; Lefkowitz, R. A.; Panageas, K.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • CTLA-4 antibodies: New directions, new combinations
    Journal Article

    Funt, S. A.; Page, D. B.; Wolchok, J. D.; Postow, M. A.
    Oncology (Norwalk) (2014)

    Fulltext@MSK | Save
  • Immunologic checkpoints in cancer therapy: Focus on the programmed death-1 (PD-1) receptor pathway
    Journal Article

    Momtaz, P.; Postow, M. A.
    Pharmacogenomics and Personalized Medicine (2014)

    Fulltext@MSK | Save
  • Phase IB/II study of LEE011 (CDK4/6 inhibitor) and LGX818 (BRAF Iinhibitor) in BRAF-mutant melanoma
    Meeting Abstract

    Taylor, M.; Sosman, J.; Gonzalez, R.; Carlino, M. S.; Kittaneh, M.; Lolkema, M. P.; Miller, W.; Marino, A.; Zhang, V.; Bhansali, S. G.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status in a phase 1 trial of nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Kluger, H.; Sznol, M.; Callahan, M.; Postow, M.; Gordon, R.; Segal, N. H.; Rizvi, N.; Lesokhin, A.; Atkins, M. B.; Kirkwood, J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-programmed death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H.; Callahan, M. K.; Postow, M. A.; Gordon, R.; Seal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Asia-Pacific Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Genetic basis for clinical response to CTLA-4 blockade in melanoma
    Journal Article

    Snyder, A.; Makarov, V.; Merghoub, T.; Yuan, J.; Zaretsky, J. M.; Desrichard, A.; Walsh, L. A.; Postow, M. A.; Wong, P.; Ho, T. S. ; more...
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save